AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

SRF Ltd. Regulatory Filings 2026

Mar 31, 2026

Regulatory Filings

Opens in your device viewer

The Corporate Relationship Department, BSE Limited 1[st] Floor, New Trading Ring Rotunda Building, P.J. Towers Dalal Street, Mumbai 400 001

National Stock Exchange of India Limited “Exchange Plaza” Bandra-Kurla Complex Bandra (E) Mumbai 400 051 Scrip Code-SRF

Scrip Code- 503806

SRF/SEC/BSE/NSE

31.03.2026

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sir,

This disclosure is being made pursuant to the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (“LODR”).

Disclosures under Schedule III, Part-A, Para A (Clause 20) of LODR is given below:


i) Name of Authority	Additional Commissioner of CGST and Central Excise- Chennai North Commissionerate

ii) Nature and details of the action(s) taken, initiated or order(s) passed;	The tax authority has issued a demand order for Rs. 1,03,10,343 along with an equal amount of penalty and applicable interest disallowing certain CENVAT credit claimed by the Company for the period from 2005–2011.

iii) Date of receipt of direction or order, including any ad-interim or interim orders, or anyother communication from the authority;	30-03-2026 at 11.24 a.m.

iv) Details of the violation(s)/contravention(s) committed or alleged to be committed;	The department has disallowed certain CENVAT credit availed by the Company during the period from 2005 to 2011 and has issued a demand order along with an equal amount of penalty and applicable interest.

v) impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible.	The Company is examining the order and shall pursue appropriate legal remedies by filing an appeal in due course. The management does not expect any material adverse impact beyond the amount disclosed.